Cargando…
Arctigenin functions as a selective agonist of estrogen receptor β to restrict mTORC1 activation and consequent Th17 differentiation
Arctigenin was previously proven to inhibit Th17 cell differentiation and thereby attenuate colitis in mice by down-regulating the activation of mechanistic target of rapamycin complex 1 (mTORC1). The present study was performed to address its underlying mechanism in view of estrogen receptor (ER)....
Autores principales: | Wu, Xin, Tong, Bei, Yang, Yan, Luo, Jinque, Yuan, Xusheng, Wei, Zhifeng, Yue, Mengfan, Xia, Yufeng, Dai, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356633/ https://www.ncbi.nlm.nih.gov/pubmed/27863380 http://dx.doi.org/10.18632/oncotarget.13338 |
Ejemplares similares
-
Pathological Consequences of Hepatic mTORC1 Dysregulation
por: Cho, Chun-Seok, et al.
Publicado: (2020) -
Mechanisms and consequences of hepatic regulation of mTORC1 by metformin
por: Howell, Jessica J, et al.
Publicado: (2014) -
Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation
por: Yuan, Xusheng, et al.
Publicado: (2017) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)